Aims: To observe the effect of cigarette smoke (CS) on the small bowel and colon in mice and to attempt to explain the potential mechanisms that account for these effects. Methods: Male BALB/c mice age 6-8 weeks were randomly divided into a CS group and a control group (n = 10 per group). CS mice were exposed to CS (five cigarettes each time, four times a day for 5 days a week using Hamburg II smoking machine and CS was diluted with air at a ratio of 1:6) for 10 weeks, and control mice were exposed to room air. After 10 weeks, mice were sacrificed for analysis (colon and small bowel). Results: CS exposure impaired the intestinal barrier of the small bowel, based on evidence that CS mice exhibited increased intestinal permeability, bacterial translocation, intestinal villi atrophy, damaged tight junctions and abnormal tight junction proteins. These changes were partly mediated through the activated NF-κB (p65) signalling pathway. However, no obvious changes associated with the intestinal barrier were identified in the small bowel of control mice or the colons of control or CS mice. Conclusions: CS is associated with intestinal barrier dysfunction in the small intestine but not in the large intestine of mice.
Introduction
Cigarette smoke (CS) remains the most widely studied and replicated environmental trigger for inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC) 1 . CS is protective in UC with a lower incidence, better clinical course, and less need for surgery among smokers, but the opposite is true for CD 1, 2 . However, the mechanisms for the differential effect on both diseases remain unclear. Attempts to account for the association between smoking and IBD have been hampered by the fact that the pathogenesis of both UC and CD remains unknown. One of the factors linking smoking and IBD might be intestinal permeability, which is considered to play a key role in the pathogenesis of both diseases 3, 4 and can be influenced by CS 5, 6 . However, the effects of smoking on intestinal permeability in patients with IBD and healthy volunteers are also controversial. Prytz et al. showed that smoking "tightens" the gut in healthy volunteers and suggested that a lower intestinal permeability in smokers might explain the protective effect of smoking in ulcerative colitis 7 . Suenaert et al. found that smoking could reduce the effect of NSAIDs on intestinal permeability, but no effect of smoking was observed on the baseline permeability of the small intestine in healthy volunteers 8 . However, in patients with ulcerative colitis, Benoni et al. demonstrated no difference in intestinal permeability between smokers and nonsmokers 9 . These studies failed to clarify the complexity of the impact of CS on intestinal permeability.
Although more attention has been paid to this issue, the underlying mechanism(s) of the dual effect of smoking on UC and CD still remained unclear 5, 6 . In our study, we aimed to observe the impact of CS on the small bowel and colon in mice without a special genetic background and to attempt to account for the potential mechanism.
Materials and methods

Mice
Male BALB/c mice age 6-8 weeks and weighing 16-20 g were obtained from the Animal Center of Jin Ling Hospital. All mice were housed in plastic-bottomed wire-lidded cages and kept at 25°C with a 12-h light/dark cycle. Mice had free access to water and were fed with a regular mouse chow. Body weight was measured at least once a week during the exposure period. The experimental procedures were performed in accordance with the Guidelines for Animal Experiments at Jin Ling Hospital and approved by the Ethics Committee of Jin Ling Hospital (Jiangsu, China).
Cigarette smoke exposure and experimental design
Mice were randomly divided into two groups (n = 10 per group). The first group was exposed to cigarette smoke for 10 weeks (CS), and the second group to room air for 10 weeks (Control). Considering the lifespan of a laboratory mouse, 10 weeks of smoking corresponds approximately to 10 years of smoking in humans 10 . Mice (CS group) were exposed to main stream as described previously 11, 12 . Briefly, mice were exposed to the mainstream cigarette smoke of five cigarettes (Reference Cigarette 3R4F without filter; University of Kentucky, Lexington, KY, USA), four times a day with 30-minute smoke-free intervals, 5 days a week. The Hamburg II smoking machine (Borgwaldt KC, Hamburg, Germany) was used in our study, and puff duration and volume were 2 s and 35 ml, respectively. Cigarette smoke was diluted with air at a ratio of 1:6. Carboxyhaemoglobin in the sera of smoke-exposed mice reached a non-toxic level of 7.90 ± 0.28% (compared with 0.59 ± 0.21% in air-exposed mice), which is similar to blood concentrations of carboxyhaemoglobin in human smokers 13 . The levels of serum cotinine in CS mice were 150.50 ± 4.02 ng/ml (compared with less than 8 ng/ml in control mice), which is similar to that in human smoker 14 . Control group mice were exposed to filtered fresh air. Studies were performed 1-2 days after the last exposure to CS/air.
Levels of carboxyhaemoglobin and cotinine
Blood samples were collected from the caudal vein and stored at − 80°C for measurements of carboxyhaemoglobin and cotinine. The serum levels of carboxyhaemoglobin were measured using a blood gas analyser (Instrumentation Laboratory, Lexington, MA). Cotinine (nicotine metabolite) serum levels were determined using a cotinine assay kit (Orasure Technologies, Bethlehem, PA) in accordance with the manufacturer's recommendations.
Intestinal permeability in vivo
Mice were fasted for 4 h and then administered fluorescein isothiocyanate (FITC)-dextran (4 kDa; Sigma) by gavage at a dose of 600 mg·kg − 1 . After 4 h, the mice were killed by cervical dislocation and bled by cardiac puncture. Serum was isolated using centrifugation, and serum FITC levels were evaluated using fluorometry.
Analyse the permeability of colon and small bowel, respectively
The permeability of mouse intestines was measured by performing the Ussing Chamber Analyses as described in Ref. 15 . The colon and small bowel were removed from the animals and the luminal contents were gently rinsed out with PBS. Then, bowel segments were placed into oxygenated Krebs buffer (115 mM NaCl, 8 mM KCl, 1.25 mM CaCl 2 , 1.2 mM MgCl 2 , 2.0 mM KHPO 4 , 25 mM NaCO 3 , pH 7.33-7.37) at 37°C. Small bowel sections were obtained proximal to the cecum, whereas large bowel sections were obtained proximal to the anus. Excised tissues were opened by dissection along the mesentery axis and mounted on 2.8 mm × 11.0 mm oblong sliders (Chamber Systems P2304; Warner Instruments, LLC, USA) with the luminal side down. The sliders were loaded into a four-chamber Ussing chamber system (Chamber Systems CSYS-4HA; Warner Instruments, LLC, USA) that was pre-calibrated. Krebs buffer was added to both chambers, whereas 10 mM glucose was added to the serosal side as an energy source and 10 mM mannitol was added to the luminal side to maintain osmotic balance. Agar-salt bridges were used to both monitor potential difference across the membrane and apply the appropriate short-circuit current (I sc ) to maintain the potential difference at zero as controlled through an automated voltage clamp. The system is controlled through the Acquire and Analyse software (Physiological Systems), which modulates voltage and current controls remotely. The tissue was allowed to equilibrate for 15 min before I sc readings were taken. In this way, we were able to measure transepithelial electric resistance (TEER) in intestinal epithelial tissues. After the tissues had equilibrated in the Ussing chamber, and baseline I sc readings were acquired, 10 − 5 M horseradish peroxidase (HRP, Type VI; Sigma) was added to the luminal chambers to act as a probe for macromolecular permeability; 500 μL samples were taken from the serosal chambers at 30-min intervals for 2 h and replaced by 500 μL of fresh Krebs buffer to maintain constant volume. A modified Worthington method was used to evaluate the enzymatic activity of HRP in the serosal samples as described in Ref. 15 .
Bacterial translocation
Using aseptic techniques, tissue samples from the mesenteric lymph nodes (MLN, two samples for each mouse) and caudal lymph nodes (CLN) were taken for bacteriological cultures. Collected tissue samples were weighed and 0.1 g of each tissues was homogenised in a tissue grinder with 0.9 ml sterile saline. The homogenates were diluted and 100 μl dilutions were taken and cultured on Mac-Conkey's agar (Sigma) at 37°C for 24 h. Bacterial growth in the plates was expressed as colony-forming units/g of tissue. The result of cultures was considered to be positive when more than 10 2 colonies/g of tissue were found 16 .
Histological examinations
Histologic evaluation was performed in H&E-stained sections of the colon (distal colon and proximal colon) and small bowel (distal small bowel and proximal small bowel) tissues fixed in 10% formalin solution. Slides were reviewed in a blinded fashion and assessed according to a previously validated intestinal histologic inflammatory score with a range from 0 to 9. 17 Briefly, histologic indices were evaluated for the presence of (1) active inflammation (infiltration with neutrophils), (2) chronic inflammation (lymphocytes, plasma cells, and macrophages in the mucosa and submucosa), and (3) villus distortion (flattening and/or widening of normal villus architecture). For each index, a score ranging from 0 (normal histology) to 3 (maximum severity of histologic changes) was applied. The sum of all 3 individual components was expressed as the total inflammatory score. Peyer's patches were not included in the calculation.
Transmission electron microscopy of tight junctions
Sections of the colon and small bowel (2 mm) were fixed for 2 h in 4% buffered glutaraldehyde. The sections were cut into smaller pieces, post-fixed in 1% osmium tetroxide (OsO 4 ), sequentially dehydrated through graded alcohols, infiltrated through Epon 812 and then embedded in resin. Thin sections were cut and stained with uranyl acetate and lead citrate, and examined with a Hitachi H-600 transmission electron microscope (Hitachi) operated at 75 kV at a magnification of 20,000 ×. Tight junctions were considered to have increased permeability when the electron-dense marker penetrated into the junctional complex.
Immunofluorescence assessment of tight junction proteins
The localisation of zona occludens-1 (ZO-1), occludin, claudin-1 proteins and NF-κB-p65 was determined by immunofluorescence as described in Ref. 18 . The intestine segments were immediately removed, washed with PBS, mounted in embedding medium, and stored at − 80°C until use. Frozen sections were cut at 10 μm, and mounted on the slides. The nonspecific background was blocked by incubation with 5% bovine serum albumin plus 5% newborn bovine serum in PBS for 30 min at room temperature. The sections were incubated with rabbit polyclonal antibody against ZO-1 (Abcam), rabbit polyclonal antibodies against occluding (Abcam), rabbit polyclonal antibody against claudin-1 (Abcam) and NF-κB-p65 (Santa Cruz Biotechnology) at 4°C overnight. The sections were probed with their respective FITC-conjugated secondary IgG antibodies. The nuclei were counterstained with DAPI (4, 6-diamidino-2-phenylindole). Slides incubated without any primary antibody were used as negative controls. Confocal analysis was performed with a confocal scanning microscope (Leica Microsystems, Heidelberg GmbH, Mannheim, Germany).
Enzyme-linked immunosorbent assay
The intestinal levels of TNF-α and IL-1β were determined by enzyme-linked immunosorbent assay (ELISA). Briefly, the intestinal mucosa tissue of the small bowel and colon were removed and stored at − 80°C until use (also for quantitative real-time PCR and Western blot analysis). When ELISA was performed, the tissues were homogenised in 1 ml of Tris-HCl buffer containing protease inhibitors (Sigma). Then, the samples were centrifuged at 3000 rpm at 4°C for 30 min, and the supernatant was frozen at − 80°C until assay. The protein concentration was determined by the Bradford assay. The levels of TNF-α and IL-1β (pg/mg) were measured using commercial ELISA kits (R&D) according to the manufacturer's instructions.
Quantitative real-time PCR analysis
The mRNA levels of TNF-α, IL-1β, defensin-α4, heat shock protein 70 (HSP 70), high mobility group box 1 (HMGB1), cytochrome P450 1A1 (CYP450 1A1) and heme oxygenase-1 (HO-1) were measured by quantitative real-time PCR analysis as described in Refs. [19] [20] [21] . Briefly, after total RNA was extracted from intestinal mucosa tissues using TRIZOL reagent (Life Technologies Inc.), the oligo (dT)-primed complementary DNA was used for reverse transcription of purified RNA. The amount of transcript of the genes of interest was measured by real-time quantitative RT-PCR assay using SYBR Green detection (Applied Biosystems, Carlsbad, CA). All reactions were independently repeated at least twice to ensure the reproducibility of the results. Primer sequences are listed in Table 1 . Expression levels of each gene were normalised using β-actin gene expression, yielding the relative expression value.
Western blot analysis
Whole-cell protein extraction and nuclear protein from the intestinal mucosa of small bowel and colon were prepared as previously described 22 . Western blot analysis was conducted as described in Ref. 23 . Briefly, protein extracts from the intestinal mucosa of the small bowel and colon were separated by 10% sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) gradient gels and transferred to nitrocellulose membranes for immunoblotting analyses. The primary antibodies were 1:1000 dilutions of rabbit polyclonal antibody against p65, p-p65, p-IKK, p-I κB, ZO-1, occludin, claudin-1, CYP450 1A1 and Histone 3 (H 3 ) or β-actin (Cell Signalling). Western blot analyses were performed with horseradish peroxidase (HRP)-conjugated secondary antibody (1:2000 dilution, Cell Signalling) using enhanced chemiluminescence Western blotting detection reagents (Amersham, Arlington Heights, IL, USA). Quantification was performed by optical density methods using the ImageJ software. The results are expressed as relative density to β-actin or H 3 , normalised to the mean value of the control group 19 .
Statistical analysis
All data analysis was performed using Statistical Package for Social Sciences (SPSS Inc., Chicago, IL, USA) software version 19.0. Continuous, normally distributed data are presented as the mean ± standard error (mean ± SEM). We used unpaired t-tests to compare parametric continuous variables. Binary and categorical data were compared by means of chisquared tests for contingency tables. Fisher's exact test was performed when cases ≤ 5. A level of P b 0.05 was considered statistically significant.
Results
CS exposure caused a slower rate of weight gain
The most obvious change caused by CS exposure was the change in the body weight of the two groups. As presented in Fig. 1 , the body weight increased steadily in all groups throughout the study. However, the rate of increase was slower in the CS group than in the control group. CS mice had lower average body weight than control mice from week 3 to week 10 (P b 0.01).
CS exposure increased intestinal permeability in the small bowel
Intestinal permeability was measured in vivo. As shown in Fig. 2(A) , CS mice had higher levels of serum dextran conjugates compared to control mice (P b 0.01). We also analysed the permeability of the colon and small bowel in an Ussing Chamber in vitro. CS mice showed decreased resistance in the small bowel but not the colon when compared to control mice (P b 0.05; Fig. 2B ). There was no significant difference in colon permeability between the two groups, but the small bowel from CS mice showed a significant increase in permeability compared with that of control mice (P b 0.01; Fig. 2C ). These data indicated that CS exposure can increase the permeability of the small bowel.
CS exposure led to bacterial translocation
In view of our results showing that CS exposure can increase intestinal permeability, this change may lead to bacterial translocation known to play an important role in the aetiology of human inflammatory bowel diseases 4 . Bacterial culture of mesenteric lymph node (MLN) and caudal lymph node (CLN) were performed as shown in Fig. 2D . The rate of bacterial translocation of the MLN was higher in CS mice compared with control mice. No significant difference was found between the two groups in the rate of bacterial translocation of the CLN. This finding combined with the above results demonstrated that intestinal barrier dysfunction can be caused by CS exposure. Interestingly, only the small bowel was involved. It appeared as though the colon had the capacity to stay injury-free. To decipher the cause, further studies were performed as follows. Figure 1 CS exposure caused a slower rate of weight gain. CS-exposed animals grew at a slower rate compared to control mice. Data are expressed as the mean ± SEM (n = 10 per group). ▾ P b 0.01 versus CS group.
CS exposure altered the microscopic structure of small bowel villi
The histological examinations of the two groups of mice are shown in Fig. 3 . The microscopic structure of the small bowel villi (including the distal small bowel and proximal small bowel) of CS mice was altered, and characterised by impaired intestinal villus structure, decreased number of intestinal villi and accumulation of inflammatory cells in the lamina propria. CS mice had a higher small bowel histologic score (including the distal small bowel and proximal small bowel) than control group, the difference was statistically significant (P b 0.01; Fig. 3B ). There was no significant difference in the colon histologic score (including the distal colon and proximal colon) between the two groups (Fig. 3D ).
As shown in Fig. 3E , hypertrophy of Peyer's patches was observed in the small bowel from CS mice (occurrence rate was 9/10), but not in control mice (figures not shown). This finding was consistent with the results of Verschuere, et al. 12 . No obvious change was found in the structure of Paneth cells from the two groups. As no obvious difference between the histologic scores of the distal and proximal intestines (small bowel or larger bowel) was found, we chose the distal small bowel and distal larger bowel as representative segments of the small bowel or large bowel for further analysis.
CS exposure damaged the morphology of tight junctions in the small bowel
The presence of impaired small bowel villi caused by CS was verified by microscopy (H&E). We also investigated the change in intestinal villus structure at the submicroscopic level to observe the morphology of tight junctions (TJ). When transmission electron microscopy analysis was performed to investigate the intestinal villi, we found that the ultrastructural morphology of TJ in the small bowel villi was altered by CS exposure. As demonstrated in Fig. 4A , decreased amounts of electron-dense materials in the TJ and abnormal desmosomes were found in the small bowel villi of CS mice. The TJ and desmosomes were intact in the Figure 2 CS exposure increased intestinal permeability in the small bowel but not in the colon. CS mice had higher serum levels of dextran conjugate compared to control mice (A). CS mice showed decreased resistance in the small bowel but not the colon compared with control mice (B). No significant difference was noted in the colon permeability between the two groups, but the small bowel of CS mice showed a significant increase in intestinal permeability compared with control mice (C). The rate of bacterial translocation of the MLN was higher in CS mice compared with control mice (D). MLN, mesenteric lymph node; CLN, caudal lymph node. Data are expressed as the mean ± SEM (n = 10 per group).
▽ P b 0.05 versus CS group. ▾ P b 0.01 versus CS group. small bowel of control mice (Fig. 4B ) and in the colons of both CS (Fig. 4C ) and control mice (Fig. 4D ).
CS exposure altered the small bowel epithelium tight junction proteins
As tight junction proteins (including claudin-1, occludin and ZO-1) contributed to the barrier function, redistribution of those proteins led to altered TJ structure. Thus, immunofluorescence technique was used to evaluate the intestinal mucosal at the molecular level, and the results are shown in Fig. 5 . We found that biotin staining (claudin-1, occludin and ZO-1), ectopic to the lamina propria or deep into the epithelial surface and some of the surface of villi, lacked focused staining in the small bowel of CS mice whereas the distribution and density of focused staining were normal in the small bowel of control mice (Fig. 5A-C ) and in the colons of both CS and control mice (Fig. 5D-F) . As shown in Fig. 6 , the concentration of claudin-1, occludin and ZO-1 in the small bowel mucosa of CS mice was found to be significantly lower when compared to those of control mice. No significant difference in colonic mucosa claudins was found between the two groups. This result combined with above findings indicated that CS exposure can cause damage to the intestinal barrier structure, which contributed to intestinal barrier dysfunction. However, the molecular mechanism still remains unknown.
CS induced NF-κB activation in the small bowel
Intestinal inflammatory factors and stress response markers were examined to identify the possible mechanism of intestinal barrier dysfunction caused by CS exposure. The mRNA of defensin-α4, HO-1, and HSP 70 was compared between the two groups (small bowel and colon) but no significant difference was found (Fig. 7A-C) . The CS mice had a higher level of HMGB1 mRNA in the small bowel than that of control group (Fig. 7D) . CS exposure significantly elevated the concentration of TNF-α protein in the small bowel of CS mice compared to that of control mice (Fig. 7E) , which was confirmed by the assessment of TNF-α mRNA expression (Fig. 7F) . The concentration of IL-1β protein in the small bowel of CS mice was also found to be significantly increased compared to control mice Figure 4 CS exposure damaged the morphology of TJ in the small bowel but not the colon (n = 10 per group). (A) In the small bowel in the CS group, the tight junction (TJ) ultrastructure was altered, and characterised by decreased electron-dense materials in the TJ and abnormal desmosomes. The TJ and desmosomes were intact in the small bowel of control mice (B) and the colon of both CS (C) and control mice (D). Arrows, tight junctions, arrow heads, and desmosomes. Scale bars = 0.2 μm. (Fig. 7G) ; however, this finding was not confirmed by the quantitative mRNA analysis ( Fig. 7H ; P = 0.087). There was no significant difference of CYP450 1A1 on the protein and mRNA level between the two groups ( Fig. 7I-J) . As the expression of TNF-α, IL-1β and HMGB1 can be mediated by the NF-kappaB (NF-κB) signalling pathway 24 , this pathway may also be activated by CS exposure. This hypothesis was verified as shown in Fig. 8 . The non-phosphorylated (Fig. 8A) and phosphorylated (Fig. 8B) forms of NF-κB p65 were all increased in the small bowel of CS mice compared to control mice. The p-IKK and p-I κB were also increased in the small bowel of CS mice (Fig. 8C) . Consistent with the results of immunofluorescence staining, we observed that the nuclear expression of NF-κB was markedly increased in the small bowel of CS mice (Fig. 8D) . However, no significant difference in the expression of NF-κB was detected in the colon of these two groups. These results indicated intestinal barrier dysfunction caused by CS exposure, at least, partly through activation of the NF-κB signalling pathway.
Discussion
To the best of our knowledge, this study is the first to examine the effects of CS on intestinal barrier function in both the small bowel and colon, using mice without special genetic background and extraneous stimulus. Our main findings can be summarised as follows: 1) CS exposure can cause intestinal barrier dysfunction of the small bowel with increased intestinal permeability and bacterial translocation; 2) the structure of small bowel epithelial barrier can be injured by CS exposure, which can contribute to intestinal barrier dysfunction; 3) the NF-κB signalling pathway can be activated in the small bowel by CS exposure, which may be partly responsible for damage to the intestinal barrier structure. Indeed, it is a very interesting phenomenon that under the same CS stimulus, only the small bowel was involved while no obvious changes could be found in the colon.
Our data showed that the small bowel of CS mice had high levels of TNF-α, IL-1β and HMGB1 expression that could Figure 5 Localisation of ZO-1, occludin and claudin-1 and DAPI (DNA) on sections of the small bowel from the two groups (A-C; n = 10 per group). Tight junction proteins (green, including ZO-1, occludin and claudin-1) and DAPI staining (blue), merged tight junction protein and DAPI, as well as amplified merged tight junction protein and DAPI images are presented. Arrows indicated that biotin staining was ectopic to the lamina propria or deep into the epithelial surface. Arrowheads indicated the lack of focused staining in the surface of villi. Abnormal claudins were found only in the small bowel of CS mice whereas the distribution and density of focused staining were nearly normal in the small bowel of control mice and colon of the two groups (D-F).
contribute to the intestinal barrier defect. TNF-α is known to induce an inflammatory response in intestinal epithelial cells 25 , which we observed in the small bowel of CS mice in our study. Recent studies have also demonstrated that TNF-α impairs the intestinal TJ barrier through different mechanisms 26 . In intestinal Caco-2 cells, treatment with TNF-α increased inulin permeability, which may correlate with NF-κB activation based on the fact that inhibition of TNF-α-induced NF-κB activation by selected NF-κB inhibitors prevented the increase in TJ permeability in Caco-2 cells 27, 28 . Tight junction proteins are known to contribute to barrier function and TJ structure. Low expression of ZO-1, occludin and claudin-1 was found in IL-10 −/− mice and patients with IBD 29, 30 , and also in the small bowel of CS mice in our study. TNF-α can also reduce the expression of these tight junction proteins partly via the NF-κB pathway 26, 29, 31 . In addition, IL-1β plays an important role in the intestinal inflammatory process, and recent studies have shown that IL-β causes increased intestinal TJ permeability and that the IL-1β-induced decrease in tight junction protein expression may also be regulated by the NF-κB pathway [32] [33] [34] [35] . HMGB1 can also be mediated by the NF-κB pathway 24 and increases the permeability of Caco-2 monolayers 36 . These studies indicated that the NF-κB signalling mediated cytokines can induce intestinal barrier defects 37 . This could partly explain the intestinal barrier dysfunction caused by CS exposure in our study.
Both clinical and animal research have demonstrated the protective role of CS in UC, which is an inflammatory disease involving the colon [38] [39] [40] . The adverse effects of CS on CD have also been fully confirmed 41, 42 . However, the mechanisms involved in the opposite effects of smoking on CD and UC are only partially understood. Although several potential mechanisms, such as modulation of mucosal immune responses, and alterations in intestinal cytokine and eicosanoid levels have been proposed, none of these hypotheses could offer a satisfying explanation 43 . Unlike UC, CD can involve both the colon and small bowel. However, studies that compared the effect of smoking on CD did not focus on the effect of cigarette smoking on the location of the disease. To our best knowledge, no epidemiologic study directly addressed the question of the effect of smoking in patients with isolated Crohn's colitis. In fact, isolated Crohn's colitis is very rare and difficult to differentiate from UC 44, 45 . This indicates that the small bowel may be the site of predilection of CD, although CD can affect the colon too. Combined with our interesting finding that, under the same CS stimulus, only the small bowel was involved, we have a reason to hypothesise that the opposite effects of smoking on UC and CD may be a consequence of the site of the disease (colon vs the small bowel) but not associated with a particular disease (UC vs CD). However, this finding needs further confirmation, especially, the observation of CS in isolated Crohn's colitis.
Stress may play an important role in the intestinal barrier dysfunction under CS exposure in our study. Stressors including hypoxic stress and psychological stress have been reported to be related to intestinal barrier dysfunction. CS mice in our study had a high level of carboxyhaemoglobin (air-exposed mice did not), which suggested CS mice might Figure 6 The concentration of claudin-1, occludin and ZO-1 in the small bowel mucosa of CS mice were found to be significantly lower compared to control mice. There was no significant difference in the colonic mucosa claudins between the two groups. Data are expressed as the mean ± SEM (n = 10 per group).
▾ P b 0.01.
undergo hypoxia stress 46 . Several studies verified that hypoxemia can induce the intestinal barrier dysfunction. In a previous study, a single, 60-minute bout of moderateto-high intensity exercise results in splanchnic hypoperfusion (decreases the supply of oxygen to the gut) and gut barrier dysfunction in healthy individuals 47 . Furthermore, this exercise-induced intestinal injury can be aggravated by ibuprofen (reducing perfusion within the splanchnic area) 48 . In addition, CS stimulation and hypoxia may induce psychological stress and result in the subsequent intestinal barrier dysfunction. Indeed, Cameron et al. found that mice under water avoidance stress developed increased permeability in the intestine 49 . Another work reported by Teitelbaum et al 50 indicated that corticotrophin-releasing factor (CRF, 50 μg/kg/day, delivered over 12 days via osmotic minipumps implanted subcutaneously) resulted in intestinal barrier dysfunction which was similar to that induced by psychological stress 49 . Therefore, further studies are needed to demonstrate whether CS exposure induced intestinal barrier dysfunction is associated with the stressors such as hypoxia and psychological stress.
The limitations in our study include: 1) we did not identify the exact element(s) in CS that can directly cause the changes in the intestinal barrier and inflammation, 2) although we found that intestinal barrier dysfunction could be caused by CS, which may occur via the NF-κB pathway, Figure 7 No significant difference was found when the mRNA expression of defensin-α4, HO-1 and HSP70 were compared between the two groups (A-C). The CS mice had a higher level of HMGB1 mRNA in small bowel than that of control group (D). CS exposure significantly elevated the concentration of TNF-α protein in the small bowel of CS mice compared to control mice (E), which was confirmed by assessing TNF-α mRNA expression (F). Concentration of IL-1β protein in the small bowel of CS mice were also found to be significantly increased compared with control mice (G); however, this finding was not confirmed by quantitative mRNA analysis (H; P = 0.087). There was no significant difference of CYP450 1A1 on the protein and mRNA level between the two groups (I, J). Data are expressed as the mean ± SEM (n = 10 per group).
▾ P b 0.01; ▽ P b 0.05.
other signalling pathways may be involved. In fact, tobacco smoke contains more than 4500 chemicals, many of them toxic or interfering with the immune system 51 . Among them, nicotine, carbon monoxide and nitrogen oxide are known to have immunomodulatory capacities and are possible mediators in the pathogenesis of IBD, but also other tobacco constituents can interact with intestinal immunity and gut function 52, 53 . The strengths of our study are summarised as follows: 1) to our best knowledge, this is the first demonstration that the impact of CS on the intestinal barrier function exhibits organ specificity, which may be a helpful account for the dual effect of smoking on UC and CD; 2) we recommend the smoking mice model in our study, which exhibit several features of human IBD including malnutrition, increased intestinal permeability and inflammation. It can be used for research of IBD and intestinal barrier function, especially in small bowel diseases.
In conclusion, this study examined the effect of CS on both the small intestine and colonic intestinal barrier function in mice with no special genetic background or extraneous stimuli. We found that CS exposure could damage both the structure and function of intestinal barrier, based on the evidence that CS mice exhibited increased intestinal permeability, bacterial translocation, intestinal villi atrophy, damaged tight junctions and abnormal tight junction proteins. However, only the small bowel was affected. Our direct evidence demonstrates that the impact of CS on intestinal barrier function exhibits organ specificity, which may help to account for the opposite effects of smoking on CD and UC. Our finding also reminds us of the importance of the site of disease in the pathogenesis of IBD. Figure 8 Both non-phosphorylated (A) and phosphorylated (B) forms of NF-κB p65 were increased in the small bowel of CS mice but there was no significant difference in NF-κB p65 in the colon of the two groups. The p-IKK and p-I κB were also found to be increased in the small bowel of CS mice (C). The subcellular localisation of NF-κB in the intestines of the two groups was determined (D, small bowel; E, colon). Detection of NF-κB in intestinal epithelial cells with antibody against NF-κB-p65. Red fluorescence indicates NF-κB. Blue fluorescence indicates the nuclei stained with DAPI. The pink colour results from the overlap of red-coloured NF-κB and blue-coloured nucleus. Data are expressed as the mean ± SEM (n = 10 per group).
